We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-4.25%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.1M
AUM Growth
-$39.1M
Cap. Flow
-$42.6M
Cap. Flow %
-48.9%
Top 10 Hldgs %
44.48%
Holding
450
New
86
Increased
61
Reduced
79
Closed
202

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$3.18M
2
JPM icon
JPMorgan Chase
JPM
+$3.16M
3
GIS icon
General Mills
GIS
+$2.29M
4
GILD icon
Gilead Sciences
GILD
+$2.29M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$4.04M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.96M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$2.56M
4
IBB icon
iShares Biotechnology ETF
IBB
+$2.03M
5
HUM icon
Humana
HUM
+$1.77M

Sector Composition

Rank Sector Weight
1 Healthcare 44.7%
2 Consumer Staples 14.06%
3 Consumer Discretionary 4.38%
4 Financials 4.11%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIG icon
251
CALL
American International
AIG
$42.7B
– –
-25,000
Closed -$2K
AIG icon
252
American International
AIG
$42.7B
– –
-2,700
Closed -$160K
AIG icon
253
PUT
American International
AIG
$42.7B
– –
-12,500
Closed -$9K
ALNY icon
254
CALL
Alnylam Pharmaceuticals
ALNY
$35.7B
– –
-15,000
Closed -$45K
AMBA icon
255
CALL
Ambarella
AMBA
$2.71B
– –
-12,500
Closed -$51K
AMBA icon
256
PUT
Ambarella
AMBA
$2.71B
– –
-12,500
Closed -$22K
ARCT icon
257
CALL
Arcturus Therapeutics
ARCT
$172M
– –
-2,857
Closed -$3K
ARCT icon
258
Arcturus Therapeutics
ARCT
$172M
– –
-2
Closed –
ASML icon
259
CALL
ASML
ASML
$671B
– –
-6,200
Closed -$98K
ASML icon
260
PUT
ASML
ASML
$671B
– –
-14,200
Closed -$13K
ASRT
261
CALL
DELISTED
Assertio
ASRT
– –
-750
Closed -$109K
ASRT
262
PUT
DELISTED
Assertio
ASRT
– –
-250
Closed -$9K
AVXL icon
263
CALL
Anavex Life Sciences
AVXL
$221M
– –
-10,000
Closed -$1K
AVXL icon
264
PUT
Anavex Life Sciences
AVXL
$221M
– –
-20,000
Closed -$31K
BABA icon
265
CALL
Alibaba
BABA
$276B
– –
-11,500
Closed -$32K
BMRN icon
266
CALL
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-48,600
Closed -$175K
BMY icon
267
CALL
Bristol-Myers Squibb
BMY
$124B
– –
-232,500
Closed -$49K
BMY icon
268
Bristol-Myers Squibb
BMY
$124B
– –
-73,537
Closed -$3.96M
BMY icon
269
PUT
Bristol-Myers Squibb
BMY
$124B
– –
-97,200
Closed -$1.31M
CAG icon
270
CALL
Conagra Brands
CAG
$6.83B
– –
-95,347
Closed -$145K
CF icon
271
CALL
CF Industries
CF
$18.7B
– –
-10,300
Closed -$19K
CHD icon
272
PUT
Church & Dwight Co
CHD
$23.2B
– –
-2,000
Closed -$5K
CHTR icon
273
PUT
Charter Communications
CHTR
$16.2B
– –
-1,324
Closed -$1K
COST icon
274
CALL
Costco
COST
$417B
– –
-12,500
Closed -$1K
CYBR
275
CALL
DELISTED
CyberArk
CYBR
– –
-28,200
Closed -$12K
9 10
11
12 13

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q4 2016 Portfolio in Review

As of Q4 2016, FT Options held 450 positions worth $87.1M, down 31% from $126M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $42.6M in Q4 2016, closing 202 positions and reducing 79 holdings. Its most notable exit was Procter & Gamble, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 40% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Constellation Brands worth $3.07M.

  • FT Options's largest Q4 2016 buy was Constellation Brands: 20,000 shares worth $3.07M.
  • FT Options added most to General Mills in Q4 2016, an estimated $2.29M increase.
  • FT Options's biggest Q4 2016 reduction was Monsanto Co, cutting an estimated $1.06M.
  • FT Options fully exited Procter & Gamble in Q4 2016, selling an estimated $4.04M.
  • FT Options's ten largest holdings make up 44% of its $87.1M portfolio in Q4 2016.
  • FT Options opened 86 new positions and closed 202 in Q4 2016.
  • FT Options's portfolio value fell 31% quarter-over-quarter to $87.1M.

Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.